1st Financial Bank South Dakota – Trademark Portfolio
Entity Type: 03
1st Financial Bank South Dakota holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 21 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include LEO, ARIES, LIBRA, VIRGO, and CANCER. The owner is based in Dupree, SD.
P.O. Box 98
Dupree, SD 57623
Showing of trademarks Trademarks
Trademark Classifications
1st Financial Bank South Dakota's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does 1st Financial Bank South Dakota have?
1st Financial Bank South Dakota has 22 U.S. trademarks filed with the USPTO. Of these, 13 registered, 4 abandoned, 5 cancelled.
What trademark classes does 1st Financial Bank South Dakota file in?
1st Financial Bank South Dakota files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are 1st Financial Bank South Dakota's most well-known trademarks?
1st Financial Bank South Dakota's registered trademark portfolio includes well-known marks such as LEO, ARIES, LIBRA, VIRGO, and CANCER. These are among 13 currently registered trademarks in the portfolio.
What is 1st Financial Bank South Dakota's trademark registration success rate?
1st Financial Bank South Dakota has a 59% trademark registration rate, with 13 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.